About us

• Mission and strategy
• Organisation
  • Governance Board
  • Steering Committee
  • Council of Trustees
  • Operational Office
  • Product development team
  • Clinical development team
• Our partners
• Financials
• Registration and documents
• Downloads
• Contact

1. TBVI »
2. About us »
3. Organisation »
4. Clinical development team »
5. Dr. Roland Dobbelaer

Roland Dobbelaer holds a PhD in biochemistry (thesis on BCG vaccines) and retired mid 2007 as head of the Section for Biological Standardisation of the Scientific Institute of Public Health in Brussels. There he was responsible for the National Control Authority Batch Release of vaccines and plasma derivatives operating in the EU Network of Official Medicines Control Laboratories.  In this position, he advised the Belgian Medicines Agency and, as a member of the EMEA CHMP Biologics Working Party, also the European Authorities in matters of licensing and regulation of biologicals. 

During a number of years until 2006 he was the chair of the WHO Expert Committee on Biological Standardisation (ECBS) and until March 2007, he chaired the EMEA CHMP Vaccines Working Party. Until January 2008 he chaired the Biological Standardisation Steering Committee of the European Directorate for the Quality of Medicines (EDQM) and the European Pharmacopoeia Expert Group N° 15 on vaccines.

Roland Dobbelaer currently acts as an advisor in regulatory and scientific matters to a number of private and public vaccine R&D projects (incl. vaccines against Pertussis, Shigellosis, Tuberculosis, Malaria, Meningitis, Influenza) and to regulatory authorities (incl. WHO, EMEA).